|
N
| |
7
|
23
| |
|
CTx
|
Median (IQR)
|
656 (492, 811)
|
141 (88, 229)
|
0.002
|
|
BSAP
|
Median (IQR)
|
44 (26, 68)
|
15 (14, 22)
|
0.005
|
|
TGF-β, ng/ml
|
Median (IQR)
|
26.3 (16.8, 30.7)
|
20.7 (17.1, 25.5)
|
0.38
|
|
Activin-A, pg/ml
|
Median (IQR)
|
2922 (1666, 9576)
|
517 (404, 775)
|
<0.001
|
|
NTx
|
Median (IQR)
|
NA
|
158 (73, 282)
|
-
|
|
P1NP
|
Median (IQR)
|
123075 (80014, 178930)
|
54334 (36692, 77623)
|
0.002
|
|
BSP
|
Median (IQR)
|
63.9 (55.3, 90.4)
|
15.9 (8.2, 32.9)
|
0.004
|
|
FACT-BP
|
Median (IQR)
|
15 (7, 36)
|
12 (5, 23)
|
0.37
|
|
BPI
|
Median (IQR)
|
57 (12, 65)
|
6 (0, 29)
|
0.049
|
|
# of SRE,
pre
, study
(n
= 25)
|
0
|
1
|
10
| |
|
1
|
0
|
9
| |
|
2
|
1
|
4
| |
|
# of SRE
, on or post,
study
(n
= 25)
|
0
|
2
|
16
| |
|
1
|
0
|
3
| |
|
2
|
0
|
3
| |
|
3
|
0
|
1
| |
|
Duration of bone mets, in months
|
Median (IQR)
|
28 (18, 41)
|
18 (12, 29)
|
0.19
|
|
Time from primary to bone mets (n = 25)
|
<2 years
|
1
|
12
| |
|
2–5 years
|
0
|
5
| |
| |
>5 years
|
1
|
6
| |
